Invitrogen™ Kit ELISA for rat p53

Ref.: BL-RE-155089Manufacturer ref.: ERA47RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.

Tumour suppressant protein, p53, is a transcription factor specific to the sequence activated by cell stress. The p53 media the cessation of the cell cycle or the apoptosis in response to damage to the DNA or the deprivation of the body's...

Accession number
P10361
Dose range
0.328 to 80 ng/ml
Sensitivity of the dosage
0.32 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Tumour suppressant protein, p53, is a transcription factor specific to the sequence activated by cell stress. The p53 media the cessation of the cell cycle or the apoptosis in response to damage to the DNA or the deprivation of the body's...

Tumour suppressant protein, p53, is a transcription factor specific to the sequence activated by cell stress. P53 media discontinuation of cell cycle or l'apoptosis in response to damage to the DNA or food deprivation for pyrimidine nucleotides. P53 is regulated in response to stress signals and stimulated to activate transcription of specific genes, resulting in the expression of p21waf1 and other proteins involved in stopping G1 or G2/M. The p53 structure includes a N-terminal end transactivation domain, a central DNA binding domain, a domain of oligomerization and a regulatory domain of the C-terminal end. There are various p53 phosphorylation sites, including Ser15 phosphorylation, which is important for p53 activation and stabilization. P53 was characterized as a factor in blocking the proliferative action of damaged cells and acting as an anticancer agent. The phosphorylation of Ser392 in p53 has been shown to be related to the formation of human tumours. P53 was also related to the effects of aging and oxidative stress and that an increase of p53 was related to the deficits of PLT in learning and memory. P53 is found in very small amounts in normal cells, however, in a variety of transformed cell lines, it is expressed in high quantities and appears to contribute to transformation and malignancy. P53 mutants that occur frequently in a number of human cancers do not bind the consensus sequence binding site of the DNA and cause loss of tumour suppressive activity.

Sensitivity

Sensitivity of the dosage: 0.32 ng/ml.

Measurement range

Dose range: 0.328 to 80 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: p53.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17798213
Specifications
Accession numberP10361
Dose range0.328 to 80 ng/ml
Sensitivity of the dosage0.32 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)24842
Gene symbol(s)Tp53
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
Targetp53
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 μl-Plasma, 50 μl-Sera, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.ERA47RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.